Coherus BioSciences Inc (CHRS) revenue is $26.6M
Coherus BioSciences Inc (CHRS) revenue is $26.6M as of 2026-06-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full CHRS research page for quote, filings, and the rest of the model. This satellite exists so “Coherus BioSciences Inc revenue” can rank with the actual number, then send you to /stock/chrs.